Skip to main content

Solvay Meets Growing Demand for its Healthcare Polymers by Naming Foster Corporation as Distributor of Udel® and Radel® Sulfone Polymers

Share to
Press release

Alpharetta, Ga. – Nov. 1, 2016--- Solvay, a leading global supplier of high-performance specialty polymers, announced today that it has appointed Foster Corporation, a top compounder and distributor of custom polymers for medical devices, as its newest distributor of Udel® polysulfone (PSU) and Radel® polyphenylsulfone (PPSU) resins for the North American Healthcare market. The appointment went into effect October 1. 

“Solvay looks forward to working with Foster to serve the fast-growing demand for Solvay’s high-performance materials in the Healthcare market,” said Jeff Hrivnak, Global Business Development Manager for Healthcare at Solvay’s Specialty Polymers Business Unit. “Strategic relationships like these are critical to our commitment to support and accelerate the innovation and growth initiatives of customers in North America.”

Foster’s new role as distributor of Udel® PSU and Radel® PPSU resins will not affect either Solvay’s order fulfillment policies or its existing distribution relationship with ResMart. Solvay Specialty Polymers will continue to accept and fill orders that are 1,000 kg (2,200 lb) or greater, while smaller quantities will still be available through ResMart – and now Foster, who will focus on supporting Solvay’s customers in Healthcare.

Solvay’s medical-grade Udel® PSU is a rigid, high-strength, transparent polymer that offers higher heat resistance and better hydrolytic stability than polycarbonate. It retains its mechanical properties when exposed to steam and other sterilization techniques. Radel® PPSU is a super-tough, transparent polymer that can withstand more than 1,000 cycles of steam sterilization without significant loss of properties. This makes it an excellent choice for sterilization cases and trays, surgical instrument handles and other reusable medical devices.

Solvay Specialty Polymers’ experience as a reliable materials supplier in the healthcare field spans more than 25 years. The company is a leading manufacturer of healthcare polymers, offering a broad range of high-performance, medical-grade polymers for orthopedic applications, sterilization cases and trays, medical and dental devices. Solvay also offers a family of Solviva® Biomaterials for use in a range of implantable devices.

About Foster Corporation

For over twenty five years Foster Corporation has been serving medical device and pharmaceutical manufacturers with industry leading technology and service in biomedical materials. These include custom medical compounds, implantable materials, drug/polymer blends and polymer distribution. Within ISO 13485:2003 and ISO 9001:2008 facilities, Foster offers comprehensive support to customers from formulation development through production. More information is available at Solvay

Solvay Specialty Polymers manufactures over 1500 products across 35 brands of high-performance polymers – fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, aromatic ultra-high performance polymers, high barrier polymers and cross-linked high-performance compounds – for use in Aerospace, Alternative Energy, Automotive, Healthcare, Membranes, Oil and Gas, Packaging, Plumbing, Semiconductors, Wire & Cable, and other industries. Learn more at

An international chemical and advanced materials company, Solvay assists its customers in innovating, developing and delivering high-value, sustainable products and solutions which consume less energy and reduce CO2 emissions, optimize the use of resources and improve the quality of life. Solvay serves diversified global end markets, including automotive and aerospace, consumer goods and healthcare, energy and environment, electricity and electronics, building and construction as well as industrial applications. Solvay is headquartered in Brussels with about 30,900 employees spread across 53 countries. It generated pro forma net sales of € 12.4 bn in 2015, with 90% made from activities where it ranks among the world’s top 3 players. Solvay SA (SOLB.BE) is listed on Euronext in Brussels and Paris (Bloomberg: SOLB:BB - Reuters: SOLB.BR).